3SBio Inc - Company Profile
Powered by 
All the data and insights you need on 3SBio Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date 3SBio Inc Strategy Report
- Understand 3SBio Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
3SBio Catalyst Calendar
Proactively evaluate 3SBio Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of 3SBio Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 01 Oct 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 04 Aug 2020 | Phase II Trial Initiation | Sunshine Guojian Pharmaceutical Shanghai Co Ltd | 688336 | cetuximab biosimilar | Oncology | Metastatic Colorectal Cancer | Clinical Trial Registry |
| 30 Jun 2020 | Phase II Trial Completion | 3SBio Inc; Shenzhen Sciprogen Bio-pharmaceutical Co Ltd | 1530 | RD-001 | Hematological Disorders | Anemia in Chronic Kidney Disease (Renal Anemia) | Clinical Trial Registry |
| 01 May 2020 | Phase I Trial Initiation | 3SBio Inc; Shenyang Sansheng Pharmaceutical Co Ltd | 1530 | SSS-17 | Hematological Disorders | Anemia in Chronic Kidney Disease (Renal Anemia) | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer